U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Science & Research
  3. Science and Research Special Topics
  4. Peer Review of Scientific Information and Assessments
  5. Peer Review Plan: Drug Residues in Milk and Milk Products Risk Ranking Approach
  1. Peer Review of Scientific Information and Assessments

Peer Review Plan: Drug Residues in Milk and Milk Products Risk Ranking Approach

Title of the Review:
Drug Residues in Milk and Milk Products Risk Ranking Approach

Tentative Assessment:
Influential Scientific Information

Agency Contact:
Wendy Fanaselle

Office or Center: 
CFSAN

Subject of the Review:
Draft risk ranking risk assessment approach on drug residues in milk and milk products

Purpose of the Review: 
To conduct an expert external peer review of the overall modeling approach, logical structure, assumptions made, and documentation.

Type of Review: 
Individual Reviews (Letter Review)

Timing of Review:
30 days in December, 2013

Number of Reviewers:
4 to 10

Primary Disciplines/Types of Expertise of Reviewers:
Veterinary Pharmacologist; Milk Processor; Chemist/ Pharmacist; Food Safety Toxicologist; Physician with expertise in drug allergenicity; Risk Assessment Modeler.

Reviewers Selected by:
Designated Outside Organization

Public Nominations Requested for Review Panel:
No

Opportunities for the Public to Comment:
Yes

If yes, briefly state how and when will these opportunities be provided: 
The Draft Drug Residues in Milk and Milk Products Risk Ranking Approach document will be posted for public comment with the review comments when the review is complete.

Peer Reviewers Provided with Public Comments: 
No

Back to Top